Allerkast Tablets
Montelukast Sodium 10 mg + Levocetirizine HCl 5 mg
Clinical Differentiators & Advantages
PCD Franchise Distribution
Verify if exclusive marketing and distribution rights for Allerkast Tablets are currently vacant in your target district.
Active Chemical Compounds & Molecular Architecture
Validated chemical entities, 2D skeletal bond diagrams, empirical molecular formulas, and receptor-level modes of action
Leukotriene receptor antagonist preventing bronchoconstriction and airway edema.
Third-generation non-sedative antihistamine reducing nasal airflow resistance and itching.
Approved Clinical Indications & Disease Burden
Pharmacodynamic Mechanism of Action
Complete dual allergic blockade: Montelukast competitively blocks cysteinyl leukotriene (CysLT1) receptors in the bronchial and nasal mucosa, suppressing eosinophilic infiltration and edema. Levocetirizine is an enantiopure 3rd-generation H1 receptor antagonist that provides non-sedating, potent peripheral histamine blockade.
Dosage & Administration Protocol
1 tablet once daily in the evening, taken with or without food.
Precautions, Warnings & Contraindications
B2B Commercial & Shipping Metrics
Moisture-sealed 5-ply export corrugation
Includes visual aids & promotional inputs
Private label & institutional supply
Standard pharmaceutical commercial tariff
Certificate of Analysis (COA), Stability Study Reports (Zone IVb), Finished Product Specs (FPS), and Material Safety Data Sheet (MSDS).
Frequently Prescribed & Stocked Together
Clinically aligned formulations commonly co-prescribed with Allerkast Tablets to improve patient outcomes and expand distributor portfolio basket size.
Recoff Syrup
Ambroxol HCl 15 mg + Guaiphenesin 50 mg + Terbutaline 1.5 mg with Menthol
“A Novel & Trusted Bronchodilator — Cough Off with Recoff”
Recoff-DX Syrup
Dextromethorphan HBr 10 mg + Phenylephrine HCl 5 mg + Chlorpheniramine Maleate 2 mg
“Safe & Reliable Anti-Cough Solution — An Ideal Anti-Cough Therapy”